Long-term safety of biologic and targeted synthetic disease modifying drugs in rheumatology
K Barth, H Gill, N Singh - Current Opinion in Rheumatology, 2024 - journals.lww.com
Such well conducted trials are needed to gather long term comparative safety data of
DMARDs. In the interim, real world observational studies also have a role to play in our …
DMARDs. In the interim, real world observational studies also have a role to play in our …
Breakthrough SARS-CoV-2 infection and disease flares in patients with rheumatoid arthritis: result from COVAD e-survey study
CS Santos, JP Chen, E Nikiphorou, CW Tseng… - Rheumatology …, 2024 - Springer
COVID-19 has been suggested as a possible trigger of disease flares in patients with
rheumatoid arthritis (RA). However, factors associated with disease flares remain unknown …
rheumatoid arthritis (RA). However, factors associated with disease flares remain unknown …
Characteristics Associated with COVID-19 Breakthrough Infections after Booster Vaccinations in Healthcare Workers: Insights from the TüSeRe: exact Study
G Uzun, A Bareiß, M Becker, K Althaus… - Journal of Clinical …, 2024 - mdpi.com
Background: The prevalence of COVID-19 breakthrough infections in healthcare workers
(HCWs) remains an issue of concern. This study examines the different characteristics …
(HCWs) remains an issue of concern. This study examines the different characteristics …
Coronaimpfung unter Immunsuppression
R Hasseli-Fräbel, C Kneitz, RE Voll… - Zeitschrift für …, 2024 - Springer
Zusammenfassung SARS-CoV‑2 („severe acute respiratory syndrome coronavirus type 2 “)
spielt auch weiterhin eine große Rolle als schwere und potenziell tödliche …
spielt auch weiterhin eine große Rolle als schwere und potenziell tödliche …